Safety and Tolerability of Lu AF95245 in Healthy Young Men

NCT04199585 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped new safety data from another study

Conditions

Healthy

Interventions

DRUG: Lu AF95245
DRUG: Lu AF95245 14C radiolabelled spiked dosage
DRUG: Placebo

Sponsor

H. Lundbeck A/S